0

    511509

    VIVOBIOT

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    VIVO BIO TECH LTD. Share Price Today

    Investment Returns

    Over 1 Month -7.83% Over 3 Months -23.37% Over 6 Months -25.64% Over 1 Year -36.40%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    VIVO BIO TECH LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 48.20
    • P/E Ratio (TTM) -15.28
    • Beta 1.03
    • Book Value / share 41.27
    • Return on equity 6.05%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.18
    info icon alternate text

    VIVO BIO TECH LTD. Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 14.14
    Operating Expense 13.86
    Net Profit 0.18
    Net Profit Margin (%) 1.27
    Earnings Per Share (EPS) 0.08
    EBITDA 5.10
    Effective Tax Rate (%) 44.11
    Particulars MAR 2026 (Values in Cr)
    Revenue 13.77
    Operating Expense 13.22
    Net Profit -5.44
    Net Profit Margin (%) -39.50
    Earnings Per Share (EPS) -2.65
    EBITDA 4.21
    Effective Tax Rate (%) -27050.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 13.37
    Operating Expense 11.92
    Net Profit 1.26
    Net Profit Margin (%) 9.42
    Earnings Per Share (EPS) 0.57
    EBITDA 5.64
    Effective Tax Rate (%) 20.25
    Particulars SEP 2025 (Values in Cr)
    Revenue 13.02
    Operating Expense 11.64
    Net Profit 0.87
    Net Profit Margin (%) 6.68
    Earnings Per Share (EPS) 0.45
    EBITDA 5.55
    Effective Tax Rate (%) 42.38
    Particulars JUN 2025 (Values in Cr)
    Revenue 12.42
    Operating Expense 11.04
    Net Profit 1.37
    Net Profit Margin (%) 11.03
    Earnings Per Share (EPS) 0.76
    EBITDA 5.66
    Effective Tax Rate (%) 9.21
    Particulars MAR 2026 (Values in Cr)
    Revenue 52.57
    Operating Expense 47.82
    Net Profit -1.94
    Net Profit Margin (%) -3.69
    Earnings Per Share (EPS) -0.93
    EBITDA 21.06
    Effective Tax Rate (%) 142.35
    Particulars MAR 2025 (Values in Cr)
    Revenue 46.67
    Operating Expense 42.39
    Net Profit 7.57
    Net Profit Margin (%) 16.22
    Earnings Per Share (EPS) 4.95
    EBITDA 25.59
    Effective Tax Rate (%) 16.62
    Particulars MAR 2024 (Values in Cr)
    Revenue 44.88
    Operating Expense 40.87
    Net Profit 2.52
    Net Profit Margin (%) 5.61
    Earnings Per Share (EPS) 1.69
    EBITDA 21.11
    Effective Tax Rate (%) 37.77
    Particulars MAR 2023 (Values in Cr)
    Revenue 51.62
    Operating Expense 47.05
    Net Profit 2.63
    Net Profit Margin (%) 5.09
    Earnings Per Share (EPS) 1.77
    EBITDA 21.53
    Effective Tax Rate (%) 42.73
    Particulars MAR 2022 (Values in Cr)
    Revenue 51.39
    Operating Expense 47.01
    Net Profit 2.20
    Net Profit Margin (%) 4.28
    Earnings Per Share (EPS) 1.56
    EBITDA 15.90
    Effective Tax Rate (%) 50.78
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 41.15
    ROE % 5.68
    ROCE % 8.99
    Total Debt to Total Equity 0.96
    EBITDA Margin 44.45
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 36.50
    ROE % 4.76
    ROCE % 9.88
    Total Debt to Total Equity 1.27
    EBITDA Margin 46.86
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 34.81
    ROE % 5.35
    ROCE % 10.97
    Total Debt to Total Equity 1.31
    EBITDA Margin 41.89
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 32.56
    ROE % 4.91
    ROCE % 9.25
    Total Debt to Total Equity 1.10
    EBITDA Margin 31.50
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 30.63
    ROE % 15.03
    ROCE % 18.65
    Total Debt to Total Equity 0.73
    EBITDA Margin 34.53
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 41.32
    ROE % 6.05
    ROCE % 9.37
    Total Debt to Total Equity 0.93
    EBITDA Margin 45.08
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 36.50
    ROE % 4.74
    ROCE % 10.06
    Total Debt to Total Equity 1.23
    EBITDA Margin 47.46
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 34.81
    ROE % 5.31
    ROCE % 11.16
    Total Debt to Total Equity 1.27
    EBITDA Margin 42.35
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 32.57
    ROE % 4.91
    ROCE % 9.47
    Total Debt to Total Equity 1.05
    EBITDA Margin 31.48
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 30.64
    ROE % 15.03
    ROCE % 19.31
    Total Debt to Total Equity 0.67
    EBITDA Margin 34.53
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.28
    Total Assets 143.23
    Total Liabilities 143.23
    Total Equity 77.90
    Share Outstanding 1
    Price to Book Ratio 0.82
    Return on Assets (%) 5.08
    Return on Capital (%) 5.52
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.38
    Total Assets 137.13
    Total Liabilities 137.13
    Total Equity 54.39
    Share Outstanding 1
    Price to Book Ratio 1.17
    Return on Assets (%) 1.84
    Return on Capital (%) 1.98
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.37
    Total Assets 123.03
    Total Liabilities 123.03
    Total Equity 51.87
    Share Outstanding 1
    Price to Book Ratio 0.55
    Return on Assets (%) 2.15
    Return on Capital (%) 2.32
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.71
    Total Assets 122.48
    Total Liabilities 122.48
    Total Equity 47.12
    Share Outstanding 1
    Price to Book Ratio 1.22
    Return on Assets (%) 1.79
    Return on Capital (%) 1.92
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.16
    Total Assets 79.52
    Total Liabilities 79.52
    Total Equity 42.52
    Share Outstanding 1
    Price to Book Ratio 1.56
    Return on Assets (%) 7.14
    Return on Capital (%) 7.73
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.20
    Total Assets 141.28
    Total Liabilities 141.28
    Total Equity 78.19
    Share Outstanding 1
    Price to Book Ratio 0.82
    Return on Assets (%) 5.35
    Return on Capital (%) 5.82
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.31
    Total Assets 134.80
    Total Liabilities 134.80
    Total Equity 54.39
    Share Outstanding 1
    Price to Book Ratio 1.17
    Return on Assets (%) 1.87
    Return on Capital (%) 2.01
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.99
    Total Assets 120.80
    Total Liabilities 120.80
    Total Equity 51.87
    Share Outstanding 1
    Price to Book Ratio 0.55
    Return on Assets (%) 2.18
    Return on Capital (%) 2.35
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.46
    Total Assets 120.29
    Total Liabilities 120.29
    Total Equity 47.14
    Share Outstanding 1
    Price to Book Ratio 1.22
    Return on Assets (%) 1.83
    Return on Capital (%) 1.96
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.09
    Total Assets 77.30
    Total Liabilities 77.30
    Total Equity 42.54
    Share Outstanding 1
    Price to Book Ratio 1.56
    Return on Assets (%) 7.35
    Return on Capital (%) 7.98
    Particulars MAR 2025 (Values in Cr)
    Net Income 8.79
    Cash from Operations 15.37
    Cash from Investing -15.84
    Cash from Financing 3.90
    Net change in Cash -0.10
    Free Cash Flow 37.64
    Particulars MAR 2024 (Values in Cr)
    Net Income 4.06
    Cash from Operations 18.58
    Cash from Investing -7.95
    Cash from Financing -7.55
    Net change in Cash 0.01
    Free Cash Flow 26.53
    Particulars MAR 2023 (Values in Cr)
    Net Income 4.62
    Cash from Operations 18.17
    Cash from Investing -3.99
    Cash from Financing -11.17
    Net change in Cash -0.33
    Free Cash Flow 22.17
    Particulars MAR 2022 (Values in Cr)
    Net Income 4.47
    Cash from Operations 20.09
    Cash from Investing -51.11
    Cash from Financing 35.01
    Net change in Cash 0.54
    Free Cash Flow 71.20
    Particulars MAR 2021 (Values in Cr)
    Net Income 8.61
    Cash from Operations 20.64
    Cash from Investing -22.82
    Cash from Financing 8.78
    Net change in Cash 0.13
    Free Cash Flow 43.46
    Particulars MAR 2025 (Values in Cr)
    Net Income 9.08
    Cash from Operations 15.94
    Cash from Investing -15.84
    Cash from Financing 3.90
    Net change in Cash -0.10
    Free Cash Flow 38.21
    Particulars MAR 2024 (Values in Cr)
    Net Income 4.05
    Cash from Operations 18.88
    Cash from Investing -7.95
    Cash from Financing -7.55
    Net change in Cash 0.32
    Free Cash Flow 26.83
    Particulars MAR 2023 (Values in Cr)
    Net Income 4.60
    Cash from Operations 18.06
    Cash from Investing -3.99
    Cash from Financing -11.20
    Net change in Cash -0.47
    Free Cash Flow 22.06
    Particulars MAR 2022 (Values in Cr)
    Net Income 4.47
    Cash from Operations 19.88
    Cash from Investing -51.10
    Cash from Financing 35.04
    Net change in Cash 0.36
    Free Cash Flow 70.99
    Particulars MAR 2021 (Values in Cr)
    Net Income 8.62
    Cash from Operations 20.56
    Cash from Investing -22.82
    Cash from Financing 8.83
    Net change in Cash 0.10
    Free Cash Flow 43.38
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 42.42 17.60 2.05 325.08 23.12 43.00
    BLISS GVS PHARMA LTD 488.95 39.37 4.35 5194.80 118.35 552.90
    CIPLA LTD. 1450.00 32.73 3.40 117137.57 1165.55 1672.20
    FERMENTA BIOTECH LTD. 546.75 25.57 3.95 1609.14 256.40 551.25
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 42.42 29.66 5.46 325.08 23.12 43.00
    AMRUTANJAN HEALTH CARE LTD. 517.35 23.19 4.03 1495.69 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8173.90 106.82 23.41 20434.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 488.95 52.92 4.49 5194.80 118.35 552.90

    VIVO BIO TECH LTD. shareholding pattern

    Holding
    69.38%
    30.61%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    VIVO BIO TECH LTD. Technicals Summary

    21.70 0.74 redarrow
    red-green-graph indicator
    14 Bearish
    2 Bullish
    • 5 Days 21.60
    • 26 Days 22.80
    • 10 Days 22.00
    • 50 Days 23.70
    • 12 Days 22.10
    • 100 Days 25.10
    • 20 Days 22.60
    • 200 Days 27.70
    21.35 PIVOT
    First Support 20.69 First Resistance 22.19 Second Support 19.85 Second Resistance 22.85 Third Support 19.19 Third Resistance 23.69
    RSI 36.49 ADX 34.45 MACD -0.68 Williams % R -60.45 Commodity Channel Index (CCI) -116.98
    Date 2026-08-04 Week 20535.00 Same Day 28807.00 Month 20207.00
    1 Year 1.03 3 Year 0.64
    Over 1 Month
    -7.83% down
    Over 1 Year
    -36.40% down
    Over 3 Months
    -23.37% down
    Over 3 Years
    -10.19% down
    Over 6 Months
    -25.64% down
    Over 5 Years
    -22.72% down

    VIVO BIO TECH LTD. Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Vivo Bio Tech Ltd?

    Answer Field

    Vivo Bio Tech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 21.70 as on Aug 05 2026 03:15 PM.

    What is the Market Cap of Vivo Bio Tech Ltd Share?

    Answer Field

    The market cap of Vivo Bio Tech Ltd for NSE ₹ 0.00 & for BSE ₹ 48.20 as on Aug 05 2026 03:15 PM.

    What is the 52 Week High and Low of Vivo Bio Tech Ltd?

    Answer Field

    The 52 Week High and Low of Vivo Bio Tech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 43.35 and ₹ 18.36.

    What is 1 year return for Vivo Bio Tech Ltd?

    Answer Field

    The 1 year returns on the stock has been -36.40%.

    What is the P/E Ratio of Vivo Bio Tech Ltd Share?

    Answer Field

    As on Aug 05 2026 03:15 PM the price-to-earnings (PE) ratio for Vivo Bio Tech Ltd share is -15.28.

    What is the PB ratio of Vivo Bio Tech Ltd Share?

    Answer Field

    As on Aug 05 2026 03:15 PM, the price-to-book (PB) ratio for Vivo Bio Tech Ltd share is 41.27.

    How to Buy Vivo Bio Tech Ltd Share?

    Answer Field

    You can trade in Vivo Bio Tech Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Vivo Bio Tech Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Vivo Bio Tech Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Vivo Bio Tech Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |